Costa Rica vs Late-demographic dividend: Immunization, HepB3
Costa Rica
99.0%
in 2024
Late-demographic dividend
94.0%
in 2024
Costa Rica rank
1st
Late-demographic dividend rank
3rd
Immunization, HepB3 over time
- Costa Rica
- Late-demographic dividend
How they compare
Costa Rica currently reports 99.0% against 94.0% in Late-demographic dividend, a difference of 5.0%.
That makes Costa Rica's figure about 1.1 times Late-demographic dividend's.
The two have swapped places 4 times across 28 shared years of data; in 1997 it was Costa Rica ahead.
Costa Rica ranks 1st and Late-demographic dividend ranks 3rd of 188 countries.
Across the 4 decades both report, Costa Rica averaged higher in 3 and Late-demographic dividend in 1.
Head to head by decade
| Decade | Costa Rica | Late-demographic dividend | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 81.7% | 15.8% | 65.8% | Costa Rica |
| 2000s | 88.1% | 82.3% | 5.8% | Costa Rica |
| 2010s | 92.7% | 96.7% | 4.0% | Late-demographic dividend |
| 2020s | 93.8% | 93.5% | 0.3% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Costa Rica or Late-demographic dividend?
- Costa Rica, at 99.0% against 94.0% in Late-demographic dividend as of 2024.
- What is the difference in immunization, hepb3 between Costa Rica and Late-demographic dividend?
- 5.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Late-demographic dividend?
- 28 years are reported by both, from 1997 to 2024.
- How do Costa Rica and Late-demographic dividend rank globally for immunization, hepb3?
- Costa Rica ranks 1st and Late-demographic dividend ranks 3rd of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.